Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Class A common stock, $0.001 par value
-
Shares outstanding
-
162,474,849
-
Total 13F shares
-
593,267
-
Share change
-
+243,267
-
Total reported value
-
$2,581,000
-
Price per share
-
$4.35
-
Number of holders
-
7
-
Value change
-
+$1,057,998
-
Number of buys
-
6
Institutional Holders of IRONWOOD PHARMACEUTICALS INC - Class A common stock, $0.001 par value (CYTH) as of Q4 2020
As of 31 Dec 2020,
IRONWOOD PHARMACEUTICALS INC - Class A common stock, $0.001 par value (CYTH) was held by
7 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
593,267 shares.
The largest 7 holders included
AIGH Capital Management LLC, ARMISTICE CAPITAL, LLC, Worth Venture Partners, LLC, JANE STREET GROUP, LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, GOLDMAN SACHS GROUP INC, and ROYAL BANK OF CANADA.
This page lists
7
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.